These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7828287)

  • 1. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.
    Nahser PJ; Brown RE; Oskarsson H; Winniford MD; Rossen JD
    Circulation; 1995 Feb; 91(3):635-40. PubMed ID: 7828287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does pharmacologic coronary flow reserve reflect vasodilator responsiveness to increased myocardial demand in humans?
    Rossen JD; Nahser PJ; Oskarsson H; Brown RE; Winniford MD
    Coron Artery Dis; 1996 Jun; 7(6):479-84. PubMed ID: 8889365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels.
    Treasure CB; Klein JL; Vita JA; Manoukian SV; Renwick GH; Selwyn AP; Ganz P; Alexander RW
    Circulation; 1993 Jan; 87(1):86-93. PubMed ID: 8419028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.
    Nitenberg A; Valensi P; Sachs R; Dali M; Aptecar E; Attali JR
    Diabetes; 1993 Jul; 42(7):1017-25. PubMed ID: 8513969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia.
    Zeiher AM; Krause T; Schächinger V; Minners J; Moser E
    Circulation; 1995 May; 91(9):2345-52. PubMed ID: 7729020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary microvascular response to intracoronary administration of nicorandil.
    Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
    Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease.
    Sambuceti G; Marzilli M; Marraccini P; Schneider-Eicke J; Gliozheni E; Parodi O; L'Abbate A
    Circulation; 1997 Jun; 95(12):2652-9. PubMed ID: 9193434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand.
    Jones CJ; Kuo L; Davis MJ; DeFily DV; Chilian WM
    Circulation; 1995 Mar; 91(6):1807-13. PubMed ID: 7882491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and optimal dose of intracoronary adenosine 5'-triphosphate for the measurement of coronary flow reserve.
    Sonoda S; Takeuchi M; Nakashima Y; Kuroiwa A
    Am Heart J; 1998 Apr; 135(4):621-7. PubMed ID: 9539477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients.
    Antony I; Lerebours G; Nitenberg A
    Circulation; 1996 Dec; 94(12):3115-22. PubMed ID: 8989118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation.
    Duffy SJ; Castle SF; Harper RW; Meredith IT
    Circulation; 1999 Nov; 100(19):1951-7. PubMed ID: 10556220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in patients with chest pain and normal coronary arteries.
    Quyyumi AA; Cannon RO; Panza JA; Diodati JG; Epstein SE
    Circulation; 1992 Dec; 86(6):1864-71. PubMed ID: 1451258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
    Christensen CW; Rosen LB; Gal RA; Haseeb M; Lassar TA; Port SC
    Circulation; 1991 Jan; 83(1):294-303. PubMed ID: 1984887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of flow-dependent coronary dilation by ACE inhibition improves papaverine-induced maximal coronary blood flow in hypertensive patients: demonstration that large epicardial coronary arteries are more than conductance vessels.
    Antony I; Chemla D; Lerebours G; Nitenberg A
    J Cardiovasc Pharmacol; 2000 Nov; 36(5):570-6. PubMed ID: 11065216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adenosine on human coronary arterial circulation.
    Wilson RF; Wyche K; Christensen BV; Zimmer S; Laxson DD
    Circulation; 1990 Nov; 82(5):1595-606. PubMed ID: 2225364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
    De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
    Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.
    Wilson RF; White CW
    Circulation; 1986 Mar; 73(3):444-51. PubMed ID: 3948354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary vasomotor reactivity among normotensive African and white American subjects with chest pain.
    Houghton JL; Carr AA; Strogatz DS; Michel AI; Phillip JL; Kuhner PA; Smith VE; Breisblatt WM
    Am J Med; 1997 Mar; 102(3):245-51. PubMed ID: 9217592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve.
    Zijlstra F; Juillière Y; Serruys PW; Roelandt JR
    Cathet Cardiovasc Diagn; 1988; 15(2):76-80. PubMed ID: 3180211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.